中国 EN 400-660-9091

联系我们

电话:025-68037686

地址:江苏生命科技创新园F6幢1层

订购:nanjing03@biogot.com

服务:biorase01@biogot.com

合作:lvyun@biogot.com

支持:may@biogot.com

ERK1/2 (Phospho-T202/Y204) Rabbit monoclonal antibody

货号: MB66339
价格 1350
货期 现货(1-2个工作日)
25ul 50ul 100ul 200ul
No. :MB66339
Product Name :ERK1/2 (Phospho-T202/Y204) Rabbit monoclonal antibody
Swiss-Prot :P27361; P28482
Host :Rabbit
Reactivity :Human, Rat
Applications :WB, IP
Application_all :WB (1/500 - 1/1000), IP (1/10 - 1/50)
Background :Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs, such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli, including mitogens, growth factors, and cytokines, and research investigators consider it an important target in the diagnosis and treatment of cancer. Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK). Multiple p44/42 MAP3Ks have been identified, including members of the Raf family, as well as Mos and Tpl2/COT. MEK1 and MEK2 are the primary MAPKKs in this pathway. MEK1 and MEK2 activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of p44/42 have been identified, including p90RSK and the transcription factor Elk-1. p44/42 are negatively regulated by a family of dual-specificity (Thr/Tyr) MAPK phosphatases, known as DUSPs or MKPs, along with MEK inhibitors, such as U0126 and PD98059.
Product :Liquid in 50mM Tris-Glycine (pH 7.4), 0.15M NaCl, 50% Glycerol, 0.01% Sodium azide and 0.05% BSA.
Purification&Purity :The antibody was purified by immunogen affinity chromatography.
Storage&Stability :Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :Recognizes endogenous levels of ERK1/2 (pT202/Y204) protein.
BiowMW :~ 42, 44 kDa
Note :For research use only, not for use in diagnostic procedure.
Pathway :Tumor Angiogenesis,Regulation of Apoptosis,ESC Pluripotency and Differentiation Signaling Pathway,ErbB HER Signaling,G Protein-coupled Receptors Signaling to MAPK Erk,MAPK Erk in Growth and Differentiation Pathway,Jak Stat :IL-6 Receptor Signaling,Inhibition of Apoptosis,Insulin &Glucose Signaling,Mitochondrial Control of Apoptosis,Regulation of Microtubule Dynamics,T cell receptor signaling,TGFβ Smad signaling,Translational Contral elF4 and p70 S6 Kinase,Warburg Effect,MTOR signaling
Alternative Name :MAPK3; ERK1; PRKM3; Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p44-ERK1; MAPK1; ERK2; PRKM1; PRKM2; Mitogen-activated protein kinase 1; MAP kinase 1; MAPK 1; ERT1; Extracellular signal-regulated kinase 2; ERK-2; MAP kinase isoform p42; p42-MAPK; Mitogen-activated protein kinase 2; MAP kinase 2; MAPK 2
Immunogen :A synthetic phosphopeptide corresponding to residues surrounding Thr202/Tyr204 of human Erk1
Conjugate :Unconjugated
Modification :Phosphorylation
Western blot analysis of ERK1/2 (pT202/Y204) expression in C6 (A), Hela (B) whole cell lysates.
  • Anti-osteosarcoma activity of Corynoline via Src/JNK signaling-mediated cell cycle arrest and mitochondrial apoptosis
    JournalINTERNATIONAL IMMUNOPHARMACOLOGY
    ApplicationWB
    IF4.8
    SpeciesHuman

关注我们

400-660-9091

电话:025-68037686

地址:江苏生命科技创新园F6幢1层

订购:nanjing03@biogot.com

服务:biorase01@biogot.com

合作:lvyun@biogot.com

支持:may@biogot.com